Medicenna Therapeutics Corp. (MDNA) and trades at $0.16. The 52-week range is 0.15125-0.1999.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6.6, Earnings Per Share (EPS) of $0.02.
The stock has a beta of 0.77, operates in the Healthcare sector.
